Anastasia Wyce Selected Research

trametinib

1/2020

Limited antitumor activity of combined BET and MEK inhibition in neuroblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anastasia Wyce Research Topics

Disease

8	Neoplasms (Cancer) 08/2023 - 01/2008
3	Thrombocytopenia (Thrombopenia) 01/2023 - 04/2020
2	Breast Neoplasms (Breast Cancer) 11/2023 - 01/2022
2	Carcinoma (Carcinomatosis) 01/2022 - 04/2020
2	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 12/2013
2	Nausea 01/2022 - 04/2020
2	Neuroblastoma 01/2020 - 01/2013
1	Disease Progression 11/2023
1	Ovarian Neoplasms (Ovarian Cancer) 08/2023
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2023
1	Hematologic Neoplasms (Hematological Malignancy) 01/2023
1	Multiple Myeloma 01/2023
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2023
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2023
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2022
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022
1	Triple Negative Breast Neoplasms 01/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021
1	Dysgeusia (Parageusia) 04/2020
1	Diarrhea 04/2020
1	Anemia 04/2020
1	Vomiting 04/2020
1	Fatigue 04/2020
1	Carcinogenesis 01/2013
1	Muscular Diseases (Myopathy) 08/2010
1	Sarcopenia 08/2010
1	Neoplasm Metastasis (Metastasis) 01/2008

Drug/Important Bio-Agent (IBA)

7	molibresibIBA 11/2023 - 12/2013
3	Proteins (Proteins, Gene)FDA Link 12/2013 - 01/2008
2	Nuclear Proteins (Protein, Nuclear)IBA 01/2022 - 04/2020
2	4- (1- acetyl- 4- ((4- chlorophenyl)amino)- 2- methyl- 1,2,3,4- tetrahydroquinolin- 6- yl)benzoic acidIBA 01/2020 - 01/2013
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020 - 04/2018
1	ErbB Receptors (EGF Receptor)IBA 01/2024
1	Cyclin-Dependent Kinase 4IBA 01/2024
1	Fulvestrant (Faslodex)FDA Link 11/2023
1	Aromatase InhibitorsIBA 11/2023
1	Hormones (Hormone)IBA 11/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 08/2023
1	niraparibIBA 08/2023
1	Estrogen ReceptorsIBA 01/2022
1	Co-Repressor ProteinsIBA 01/2021
1	trametinibIBA 01/2020
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2020
1	MitogensIBA 01/2020
1	Mitogen-Activated Protein KinasesIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 04/2018
1	AndrogensIBA 08/2010

Therapy/Procedure

5	Therapeutics 11/2023 - 01/2008
1	Castration 01/2022
1	Drug Tapering 01/2022
1	Oral Administration 01/2013